Biotech is beating health care by double this year—here's how one investor would play it

Biotechnology stocks have soared in the fourth quarter, with the group's year-to-date gain doubling that of the broader health-care sector, and investing pros have found a few ways to capitalize.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.